KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Receivables (2017 - 2025)

Elanco Animal Health's Receivables history spans 9 years, with the latest figure at $940.0 million for Q4 2025.

  • For Q4 2025, Receivables rose 6.09% year-over-year to $940.0 million; the TTM value through Dec 2025 reached $940.0 million, up 6.09%, while the annual FY2025 figure was $940.0 million, 6.09% up from the prior year.
  • Receivables for Q4 2025 was $940.0 million at Elanco Animal Health, down from $975.0 million in the prior quarter.
  • Across five years, Receivables topped out at $1.3 billion in Q1 2023 and bottomed at $886.0 million in Q4 2024.
  • The 5-year median for Receivables is $1.1 billion (2024), against an average of $1.1 billion.
  • The largest annual shift saw Receivables skyrocketed 90.34% in 2021 before it dropped 20.35% in 2024.
  • A 5-year view of Receivables shows it stood at $1.0 billion in 2021, then decreased by 2.53% to $1.0 billion in 2022, then grew by 0.8% to $1.0 billion in 2023, then fell by 12.28% to $886.0 million in 2024, then rose by 6.09% to $940.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Receivables are $940.0 million (Q4 2025), $975.0 million (Q3 2025), and $1.1 billion (Q2 2025).